Revenant M C, Fougerouze Y, Monnet L
Ann Biol Clin (Paris). 1980;38(3):161-7.
The graphs or tables proposed by the manufacturer of reagents, the Thivolle straight lines suggested by Raby or, since 1977, Loeliger's procedure, are three possibilities offered to biologists to transform the prothrombin time into prothrombin concentrations expressed as a percentage. We have studied the possibility of interlaboratory standardisation in the case of patients treated with coumarin derivatives: firstly with the same thromboplastin under various conditions of use; secondly with five different thromboplastins under identical conditions (choosing arbitrarily one of the reagents as reference). Loeliger's procedure is the one which permits the best standardisation, but its practical application seems difficult. It seems to us that before carrying out this standardisation between laboratories, one should indicate, with the result found for the patient, the area of therapeutic activity of the thromboplastin used, as suggested by Ducker and Marbet in 1977 (these authors determined this area of therapeutic activity for 13 different reagents used in Switzerland).
试剂制造商提供的图表、拉比提出的蒂沃勒直线,或者自1977年以来洛伊利格的方法,是为生物学家提供的三种将凝血酶原时间转化为以百分比表示的凝血酶原浓度的方法。我们研究了在使用香豆素衍生物治疗的患者中进行实验室间标准化的可能性:首先是在不同使用条件下使用相同的凝血活酶;其次是在相同条件下使用五种不同的凝血活酶(任意选择一种试剂作为参考)。洛伊利格的方法是实现最佳标准化的方法,但其实际应用似乎很困难。在我们看来,在进行实验室间的这种标准化之前,应该按照达克和马尔贝在1977年所建议的那样,在患者的检测结果中注明所使用凝血活酶的治疗活性范围(这两位作者确定了瑞士使用的13种不同试剂的治疗活性范围)。